SCM
TRIB

Stonehill Capital Management’s Trinity Biotech TRIB Stock Holding History

Stonehill Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,280
Closed -$507K – 11
2024
Q1 		$507K Sell
8,280
-1,807
-18% -$127K 1.14% 5
2023
Q4 		$649K Hold
10,087
– – 1.28% 7
2023
Q3 		$1.11M Hold
10,087
– – 1.76% 6
2023
Q2 		$1.44M Sell
10,087
-500
-5% -$72.6K 0.85% 7
2023
Q1 		$1.49M Sell
10,587
-564
-5% -$87.2K 0.77% 8
2022
Q4 		$1.66M Sell
11,151
-2,637
-19% -$479K 1.79% 7
2022
Q3 		$2.21M Sell
13,788
-1,350
-9% -$261K 1.8% 11
2022
Q2 		$2.78M Hold
15,138
– – 1.85% 11
2022
Q1 		$2.41M Buy
15,138
+13,672
+933% +$2.36M 1.12% 12
2021
Q4 		$315K Sell
1,466
-1,794
-55% -$509K 0.07% 22
2021
Q3 		$1.06M Hold
3,260
– – 0.5% 14
2021
Q2 		$1.44M Hold
3,260
– – 0.7% 14
2021
Q1 		$1.84M Sell
3,260
-3,357
-51% -$2.42M 0.86% 10
2020
Q4 		$3.78M Sell
6,617
-2,480
-27% -$1.23M 1.15% 12
2020
Q3 		$2.76M Sell
9,097
-6,951
-43% -$2.41M 1.49% 10
2020
Q2 		$5.25M Sell
16,048
-3,969
-20% -$908K 1.37% 12
2020
Q1 		$3.3M Hold
20,017
– – 1.09% 16
2019
Q4 		$3.1M Buy
20,017
+931
+5% +$133K 1.06% 11
2019
Q3 		$3.46M Buy
19,086
+3,680
+24% +$959K 0.94% 11
2019
Q2 		$3.81M Buy
15,406
+4,358
+39% +$1.55M 1.09% 7
2019
Q1 		$4.72M Buy
11,048
+122
+1% +$50.3K 1.42% 10
2018
Q4 		$3.75M Buy
10,926
+5,112
+88% +$2.37M 1.75% 15
2018
Q3 		$3.49M Buy
5,814
+888
+18% +$579K 1.32% 14
2018
Q2 		$3.69M Hold
4,926
– – 1.45% 10
2018
Q1 		$3.81M Hold
4,926
– – 1.63% 7
2017
Q4 		$3.77M Hold
4,926
– – 1.53% 10
2017
Q3 		$4.14M Hold
4,926
– – 1.65% 8
2017
Q2 		$4.43M Hold
4,926
– – 1.68% 10
2017
Q1 		$4.4M Hold
4,926
– – 1.93% 13
2016
Q4 		$5.11M Buy
+4,926
New +$5.09M 2.59% 11

Other funds holding TRIB

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Stonehill Capital Management's TRIB Position: Q2 2024 in Review

Stonehill Capital Management sold out of Trinity Biotech (TRIB) in Q2 2024, closing a stake of 8,280 shares — an estimated $507K sold.

Stonehill Capital Management first reported a position in TRIB in Q4 2016 and held it in 30 quarters. The position peaked at $5.25M in Q2 2020. 20 funds tracked by Wall St. Rank hold TRIB as of Q2 2024.

  • Stonehill Capital Management reported no remaining Trinity Biotech position as of Q2 2024 after selling out during the quarter.
  • Stonehill Capital Management sold 8,280 Trinity Biotech shares in Q2 2024, an estimated $507K.
  • Stonehill Capital Management first reported a position in Trinity Biotech in Q4 2016 and held it in 30 quarters.
  • Stonehill Capital Management's Trinity Biotech position peaked at $5.25M in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2024.

Based on Stonehill Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.